EPILEPSIA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2022-12-07 ms2000001593242951

审稿速度:1.0 | 投稿命中率:5.0
经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2021-12-28 MS68862005

结果中的重要文献是在结果体现，还是在引言中描述？

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2021-12-27 MS68862005

方法的撰写顺序/逻辑顺序是什么？

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验求分享

224 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2018-01-09 小乖猫

审稿速度:1.0 | 投稿命中率:25.0
经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率

373 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2017-07-16 yangbin2015

过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了.

328 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2016-08-31 songyu88

审稿还是蛮快的

340 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2016-08-19 ms5532630230796179

经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册

193 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2015-12-29 lovetcm

回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册

392 0

[GetPortalCommentsPageByObjectIdResponse(id=2104722, encodeId=f9792104e222b, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：先给编辑发的邮件，第三天回信直接被拒，速度确实很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e05709408, createdName=ms2000001593242951, createdTime=Wed Dec 07 11:17:36 CST 2022, time=2022-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090147, encodeId=28a3109014eaa, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090148, encodeId=0c781090148cc, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578732, encodeId=002f5e873206, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550987, encodeId=672255098e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：去年尝试投了下，2周内就拒稿了，也给了意见，很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/736A754561904C02FBF919D37454C767/100, createdBy=1ea62242695, createdName=小乖猫, createdTime=Tue Jan 09 12:42:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544165, encodeId=f72a544165a5, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=328, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526616, encodeId=2ef45266161f, content=审稿还是蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Wed Aug 31 20:31:00 CST 2016, time=2016-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833267, encodeId=1e9d83326e98, content=经验：回顾性临床研究，不需要注册号。只有rct是强制性，前瞻性临床研究，建议事先注册 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155414112, createdName=ms5532630230796179, createdTime=Fri Aug 19 18:02:12 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517893, encodeId=a2b251e893d3, content=回顾性临床研究，不需要注册号。只有RCT是强制性，前瞻性临床研究，建议事先注册, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Tue Dec 29 14:29:00 CST 2015, time=2015-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517890, encodeId=160751e89056, content=请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, beContent=bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53301673195, createdName=1de17979m21(暂无匿称), createdTime=Tue Dec 29 13:13:00 CST 2015, time=2015-12-29, status=1, ipAttribution=)]

2015-12-29 1de17979m21(暂无匿称)

请问回顾性研究需不需要临床试验注册号？bingojean 2014-09-13 发表::
研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～

bingojean 2014-09-13 发表:: 研究方向：癫痫;; 接收率：约25% 审稿时间：约1个月这个杂志效率很高，第一天就有负责的编辑了，第二天就给分配助理编辑了，第二天就被助理编辑拒稿了。。。助理编辑的水平跟审稿专家差不多，我后来查了一下，此助理编辑一共自己或者跟人合作过66篇sci 文章，自己杂志就18篇，其中一篇还是我研究方向的guidelines。给的decision letter说的很委婉，说杂志竞争激烈，接收率只有25％，没有给任何意见，我是后来询问我的助理编辑，才给了点意见的，说是主要问题在于研究目的不明确，讨论不清楚，什么文献没引用，还有就是让我好好看看他写的那篇guidelines。正准备改改以后改投j neurology，希望老天能给点希望～～～

335 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务